High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial

Chong Chyn Chua; Sun Loo; John Reynolds; Ing S Tiong; Chun Yew Fong; Stephen B Ting; Shaun Fleming; Andrew W. Roberts; Andrew H Wei

doi:10.1182/blood-2022-165021

High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial

Chong Chyn Chua, Sun Loo, John Reynolds, Ing S Tiong, Chun Yew Fong, Stephen B Ting, Shaun Fleming, Andrew W. Roberts, Andrew H Wei

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	1708-1710
Number of pages	3
Journal	Blood
Volume	140
Issue number	Supplement 1
DOIs	https://doi.org/10.1182/blood-2022-165021
Publication status	Published - 1 Nov 2022
Event	Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022 - New Orleans, United States of America Duration: 10 Dec 2022 → 13 Dec 2022 Conference number: 64th https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1 (Meeting abstract published in Supplementary Issue of Blood) https://www.hematology.org/meetings/annual-meeting

Access to Document

10.1182/blood-2022-165021

Cite this

Chua, C. C., Loo, S., Reynolds, J., Tiong, I. S., Fong, C. Y., Ting, S. B., Fleming, S., Roberts, A. W., & Wei, A. H. (2022). High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial. Blood, 140(Supplement 1), 1708-1710. https://doi.org/10.1182/blood-2022-165021

@article{05639b43050d4493ac50e46ca10d82cf,

title = "High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial",

author = "Chua, {Chong Chyn} and Sun Loo and John Reynolds and Tiong, {Ing S} and Fong, {Chun Yew} and Ting, {Stephen B} and Shaun Fleming and Roberts, {Andrew W.} and Wei, {Andrew H}",

note = "Oral Abstracts 616.Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies; Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022, ASH 2022 ; Conference date: 10-12-2022 Through 13-12-2022",

year = "2022",

month = nov,

day = "1",

doi = "10.1182/blood-2022-165021",

language = "English",

volume = "140",

pages = "1708--1710",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "Supplement 1",

url = "https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1, https://www.hematology.org/meetings/annual-meeting",

}

Chua, CC, Loo, S, Reynolds, J , Tiong, IS, Fong, CY, Ting, SB , Fleming, S, Roberts, AW & Wei, AH 2022, 'High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial', Blood, vol. 140, no. Supplement 1, pp. 1708-1710. https://doi.org/10.1182/blood-2022-165021

High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial. / Chua, Chong Chyn; Loo, Sun; Reynolds, John et al.
In: Blood, Vol. 140, No. Supplement 1, 01.11.2022, p. 1708-1710.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial

AU - Chua, Chong Chyn

AU - Loo, Sun

AU - Reynolds, John

AU - Tiong, Ing S

AU - Fong, Chun Yew

AU - Ting, Stephen B

AU - Fleming, Shaun

AU - Roberts, Andrew W.

AU - Wei, Andrew H

N1 - Conference code: 64th

PY - 2022/11/1

Y1 - 2022/11/1

UR - https://www.sciencedirect.com/science/article/pii/S000649712202256X

U2 - 10.1182/blood-2022-165021

DO - 10.1182/blood-2022-165021

M3 - Meeting Abstract

SN - 0006-4971

VL - 140

SP - 1708

EP - 1710

JO - Blood

JF - Blood

IS - Supplement 1

T2 - Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022

Y2 - 10 December 2022 through 13 December 2022

ER -

High Response and Prolonged Treatment-Free Remission after a Short-Course of Modified Intensive Chemotherapy and Venetoclax in Elderly AML: An Updated Analysis of the Caveat Trial

Access to Document

Other files and links

Cite this